Recent immunohistochemical studies demonstrate a strong expression of tumor endothelial marker 1 (TEM-1), also known as endosialin/CD248, in 88.2–100% of cases and suggest that TEM1 may be a suitable biomarker for fluorescence-guided surgery in MFS [57,58]. The gene discussed is CD248; the disease is Marfan syndrome.